These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11350440)

  • 21. Tumour size and differentiation in predicting recurrence of hepatocellular carcinoma after liver transplantation: external validation of a new prognostic score.
    Marelli L; Grasso A; Pleguezuelo M; Martines H; Stigliano R; Dhillon AP; Patch D; Davidson BR; Sharma D; Rolles K; Burroughs AK
    Ann Surg Oncol; 2008 Dec; 15(12):3503-11. PubMed ID: 18777193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgical resection of hepatocellular carcinoma. Post-operative outcome and long-term results in Europe: an overview.
    Jaeck D; Bachellier P; Oussoultzoglou E; Weber JC; Wolf P
    Liver Transpl; 2004 Feb; 10(2 Suppl 1):S58-63. PubMed ID: 14762841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative analysis of factors in recurrence of hepatocellular carcinoma.
    Kanno T; Harihara S; Kinoshita H; Tamori A; Kim K; Kuroki T; Mizoguchi Y; Kobayashi K; Hirohashi K; Monna T
    Osaka City Med J; 1987 Dec; 33(2):121-35. PubMed ID: 2840621
    [No Abstract]   [Full Text] [Related]  

  • 24. Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarcinoma.
    Kim KH; Lee SG; Park EH; Hwang S; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
    Ann Surg Oncol; 2009 Mar; 16(3):623-9. PubMed ID: 19130133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of postoperative diffuse intrahepatic recurrence of hepatocellular carcinoma.
    Sonoyama T; Ochiai T; Hironaka T; Yamagishi H
    Hepatogastroenterology; 2003; 50(52):1078-84. PubMed ID: 12845986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes.
    Shah SA; Cleary SP; Wei AC; Yang I; Taylor BR; Hemming AW; Langer B; Grant DR; Greig PD; Gallinger S
    Surgery; 2007 Mar; 141(3):330-9. PubMed ID: 17349844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognosis of patients with intrahepatic recurrence after hepatic resection for hepatocellular carcinoma: a retrospective study.
    Kawano Y; Sasaki A; Kai S; Endo Y; Iwaki K; Uchida H; Shibata K; Ohta M; Kitano S
    Eur J Surg Oncol; 2009 Feb; 35(2):174-9. PubMed ID: 18325724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors affecting the prognosis of patients with hepatocellular carcinoma invading the portal vein--a retrospective analysis using 952 consecutive HCC patients.
    Koike Y; Nakagawa K; Shiratori Y; Shiina S; Imamura M; Sato S; Obi S; Teratani T; Hamamura K; Yoshida H; Omata M
    Hepatogastroenterology; 2003; 50(54):2035-9. PubMed ID: 14696460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survival and recurrence rates after resection for hepatocellular carcinoma in noncirrhotic livers.
    Lang H; Sotiropoulos GC; Brokalaki EI; Schmitz KJ; Bertona C; Meyer G; Frilling A; Paul A; Malagó M; Broelsch CE
    J Am Coll Surg; 2007 Jul; 205(1):27-36. PubMed ID: 17617329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma.
    Zuo HQ; Yan LN; Zeng Y; Yang JY; Luo HZ; Liu JW; Zhou LX
    Hepatobiliary Pancreat Dis Int; 2007 Apr; 6(2):161-5. PubMed ID: 17374575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Analysis of the risk factors influencing the prognosis of orthotopic liver transplantation for hepatocellular carcinoma and summary of relevant clinical experience].
    He YF; Fan J; Zhou J; Wu ZQ; Qiu SJ; Huang XW; Yu Y; Sun J; Xiao YS; Yang GH; Song K; Wang Z; Tang ZY; Wang YQ
    Zhonghua Yi Xue Za Zhi; 2006 May; 86(18):1232-5. PubMed ID: 16796877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pedunculated hepatocellular carcinoma: clinicopathologic study of 18 surgically resected cases.
    Yeh CN; Lee WC; Jeng LB; Chen MF
    World J Surg; 2002 Sep; 26(9):1133-8. PubMed ID: 12209243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Expression and clinical significance of VEGF and MMP-9 in hepatocellular carcinoma].
    Zhong C; Guo RP; Shi M; Wei W; Yu WS; Li JQ
    Ai Zheng; 2006 May; 25(5):599-603. PubMed ID: 16687082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Liver transplantation for the treatment of hepatocellular carcinoma].
    Chen XG; Zhu XD; Li W; Liu Y; Zou WL; Niu YJ; Wu FD; Guan ZJ; Yue Y
    Zhonghua Zhong Liu Za Zhi; 2006 Aug; 28(8):628-31. PubMed ID: 17236562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C.
    Shimoda M; Ghobrial RM; Carmody IC; Anselmo DM; Farmer DG; Yersiz H; Chen P; Dawson S; Durazo F; Han S; Goldstein LI; Saab S; Hiatt J; Busuttil RW
    Liver Transpl; 2004 Dec; 10(12):1478-86. PubMed ID: 15558585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A case of combined hepatocellular and cholangiocarcinoma showing tumor growth and invasion to the diaphragm during interferon-alpha and 5-fluorouracil combined intra-arterial chemotherapy].
    Noda T; Nagano H; Marubashi S; Kobayashi S; Takeda Y; Murakami M; Tomimaru Y; Dono K; Umeshita K; Nakayama M; Shima T; Wakasa K; Monden M; Doki Y; Mori M
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):2099-102. PubMed ID: 19106536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors in successful radiofrequency ablation therapy for malignant liver tumors.
    Sakakima Y; Inoue S; Takeda S; Kaneko T; Nakao A
    Hepatogastroenterology; 2004; 51(60):1761-5. PubMed ID: 15532821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinicopathological features of hepatocellular carcinomas (HCCs) arising in patients without chronic viral infection or alcohol abuse: a retrospective study of patients undergoing hepatic resection.
    Yokoi Y; Suzuki S; Baba S; Inaba K; Konno H; Nakamura S
    J Gastroenterol; 2005 Mar; 40(3):274-82. PubMed ID: 15830287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Melanoma antigen-1 mRNA combined with alpha-fetoprotein mRNA levels in peripheral blood of patients with hepatocellular carcinoma: a predictor of postoperative recurrence or metastasis?
    Zhang Y; Song T; Meng L; Wu X; Ba Y; Li Q
    ANZ J Surg; 2009; 79(1-2):62-9. PubMed ID: 19183381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hepatic resection for hepatocellular carcinoma--results and analysis of the current literature].
    Neeff H; Makowiec F; Harder J; Gumpp V; Klock A; Thimme R; Drognitz O; Hopt UT
    Zentralbl Chir; 2009 Apr; 134(2):127-35. PubMed ID: 19382043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.